This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Gerry Ballough
Introduction
Gerry Ballough is a notable inventor based in Drexel Hill, Pennsylvania. He has made significant contributions to the field of medical science, particularly in the treatment of ischemic neuronal reperfusion injury. His innovative approach has the potential to improve patient outcomes in various neurological conditions.
Latest Patents
Gerry Ballough holds a patent for a method and composition for the treatment of ischemic neuronal reperfusion injury. This patent focuses on methods and compositions that protect against neuropathy resulting from reperfusion injury after an ischemic condition. The treatment involves administering an antagonist of the type 3 ryanodine receptor to prevent a rise in cytosolic calcium concentration, which can lead to neuronal damage. Therapeutic compositions containing dantrolene or aminodantrolene are utilized to mitigate this risk. His work demonstrates the application of these methods in treating ischemic optic neuropathy, as well as other ischemic reperfusion neuropathies such as stroke and excitotoxic retinal damage in glaucoma.
Career Highlights
Gerry Ballough is affiliated with the University of South Florida, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating serious neurological conditions.
Collaborations
Gerry collaborates with esteemed colleagues, including Gary Brown and Harpal S Mangat, to further enhance the scope and effectiveness of his research.
Conclusion
Gerry Ballough's contributions to the field of medical science through his innovative patent highlight the importance of research in treating complex neurological conditions. His work exemplifies the potential for advancements in medical treatments that can significantly benefit patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
